A detailed history of Capital Analysts, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Analysts, LLC holds 19 shares of EW stock, worth $1,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 42 54.76%
Holding current value
$1,287
Previous $4,000 75.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $1,373 - $2,156
-23 Reduced 54.76%
19 $1,000
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $2,276 - $2,546
-27 Reduced 39.13%
42 $4,000
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $1,110 - $1,399
-18 Reduced 20.69%
69 $5,000
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $1,247 - $1,680
18 Added 26.09%
87 $6,000
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $5,428 - $6,256
69 New
69 $6,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.